Fluorouracil
NDC Package 66530-252-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Fluorouracil is used to treat various types of cancer. Marketed by Spear Dermatology Products, this product is identified by NDC 66530-252 and is authorized under FDA application ANDA203122.

Identification & Billing

NDC Package Code
66530-252-30
Package Description
30 g in 1 TUBE
Product Code
66530-252
11-Digit Billing Format
66530025230

Clinical Specifications

Proprietary Name
Fluorouracil
Dosage Form
-
Usage Information
Fluorouracil is used to treat various types of cancer. It is a chemotherapy drug that is used to slow or stop cancer cell growth. You should be tested for a DPD enzyme deficiency before you start treatment with fluorouracil. Ask your doctor for more details.

Regulatory & Marketing

Labeler Name
Spear Dermatology Products
FDA Application #
ANDA203122
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
04-23-2015
End Marketing Date
01-01-2018
Listing Expiration
01-01-2018
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 66530-252-30 identifies a specific commercial package of 30 g in 1 tube of Fluorouracil, labeled by Spear Dermatology Products. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Spear Dermatology Products on April 23, 2015. The current certification is valid through January 01, 2018.

What are the primary indications for this medication?

Fluorouracil is used to treat various types of cancer. It is a chemotherapy drug that is used to slow or stop cancer cell growth. You should be tested for a DPD enzyme deficiency before you start treatment with fluorouracil. Ask your doctor for more details.

How is this Spear Dermatology Products product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 66530025230. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
66530-252-30
11-Digit CMS (5-4-2)
66530-0252-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.